Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Collaboration Revenue $ 314,500 $ 74,696 $ 1,652,520 $ 407,518
Operating Expenses:        
Research and Development (2,259,701) (3,175,978) (6,618,509) (7,253,171)
General and Administrative (1,232,677) (1,038,822) (3,389,256) (3,540,857)
Total Operating Expenses (3,492,378) (4,214,800) (10,007,765) (10,794,028)
Operating Loss Before Other Expense (3,177,878) (4,140,104) (8,355,245) (10,386,510)
Other Income (Expense), Net:        
Interest Income 54,346 40 72,739 537
Interest Expense (304) (304) (912) (912)
Total Other Income (Expense), Net 54,042 (264) 71,827 (375)
Net Loss $ (3,123,836) $ (4,140,368) $ (8,283,418) $ (10,386,885)
Net Loss per Common Share- Basic and Diluted $ (0.07) $ (0.24) $ (0.25) $ (0.78)
Weighted Average Shares Outstanding- Basic and Diluted 43,188,546 17,204,778 32,738,363 13,267,501
Other Comprehensive Loss:        
Foreign Currency Translation Adjustments $ 6,382 $ 3,272 $ 9,622 $ 6,193
Comprehensive Loss $ (3,117,454) $ (4,137,096) $ (8,273,796) $ (10,380,692)